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Abstract
Old world hantaviruses, causing hemorrhagic fever with renal syndrome (HFRS), still present a public health problem in Asia and
Eastern Europe. The majority of cases has been recorded in China. The aim of our study was to generate human recombinant neutralizing
antibodies to a hantavirus by phage display technology. To preserve the structural identity of viral protein, the panning procedure was
performed on native Hantaan (HTN) (76-118) virus propagated in Vero-E6 cells. In total, five complete human recombinant IgG antibodies
were produced in a baculovirus expression system. All of them were able to completely neutralize HTN, and Seoul (SEO) virus in a plaque
reduction neutralization test (PRNT). Three of these antibodies could also completely neutralize Dobrava (DOB) virus but not Puumala
(PUU) virus. All antibodies bind to Hantaan virus G2 protein localized in the virus envelope. The sequence areas within the HTN
(76-118)-G2 protein detected by five selected antibodies were mapped using peptide scans. Two partial epitopes, 916-KVMATIDSF-924
and 954-LVTKDIDFD-963, were recognized, which presumably are of paramount importance for docking of the virus to host cell receptors.
A consensus motif 916-KVXATIXSF-924 could be identified by mutational analysis. The neutralizing antibodies to the most widely
distributed hantaviruses causing HFRS might be promising candidates for the development of an agent for prevention and treatment of
HFRS in patients.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The genus Hantavirus belongs to the family Bunyaviri-
dae (Schmaljohn and Dalrymple, 1983) and includes the
ethiological agents for two clinical syndromes in humans
referred to as hemorrhagic fever with renal syndrome
(HFRS) and hantavirus pulmonary syndrome (HPS). The
species Hantaan (HTN), Seoul (SEO), Puumala (PUU), and
Dobrava (DOB) virus, known to be associated with HFRS,
are most widely distributed in Asia and Europe. HTN virus
is the causative agent of severe HFRS (Lee et al., 1978)
throughout Korea and China. Its primary reservoir is the
striped field mouse Apodemus agrarius; SEO virus, trans-
mitted by the Norway rat (Rattus norvegicus) causes a
moderately severe form of HFRS occurring in China and
Korea (Lee et al., 1981, 1982); PUU virus, transmitted by
bank voles (Clethrionomys glareolus), is the cause of ne-
phropathia epidemica, a milder form of HFRS most abun-
dant in Scandinavia and Russia (Niklasson and Le Duc,
1984), and DOB virus, transmitted by the yellow-neck
mouse (Apodemus flavicollis) causes a severe form of
HFRS in the Balkans as well as in some parts of Middle and
Eastern Europe (Avsic-Zupanc et al., 1995). Hantaviruses
are primarily transmitted by virus-specific rodent hosts via
aerosols (feces, saliva, urine) by inhalation, inoculation
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through the conjunctiva, or entry through injuries of the skin
(Lee and Dalrymple, 1989). Occasionally, hantaviruses can
be transmitted by other than the primarily associated single
rodent species. Evidence for person-to-person transmission
is scarce and not considered to be a major cause of infection
(Wells et al., 1997).
Hantaviruses have a tripartite negative-strand RNA ge-
nome. The viral envelope contains two glycoproteins G1
and G2 participating in the infection of endothelial cells,
possibly via -integrin mediation (Gavrilovskaya et al.,
1998; Mackow and Gavrilovskaya, 2001). The receptor for
docking to the target cells is still unknown. However, there
is evidence for a 30 kDa protein on the cell surface to which
Hantaan virus binds (Kim et al., 2002). G1 and G2 are type
I membrane proteins anchored in the virus envelope by their
C-terminus.
The antiviral drug ribavirin, which is mainly effective in
the early phase of the disease, is currently under clinical
investigation but has not been proven to be effective for
treatment. A major problem in the treatment of HFRS is that
the majority of patients remain untreated in the early phase
of the disease since the early flu-like symptoms aggravate
diagnosis.
Yao et al. (1992) reported improved hantavirus infection
by enhanced binding of virus–antibody complexes to Fc
receptors being located, e.g., in the membrane of macro-
phages. This finding was called antibody-dependent en-
hancement (ADE). Since macrophages are susceptible to
hantavirus infection and are believed to be responsible for
spreading the infection in mice (Nagai et al., 1985), ADE
infection of macrophages is considered to be a plausible
mechanism for the rapid growth of virus. However, high
serum concentrations of neutralizing antibodies lead to an
efficient block of virus infection (Yao et al. 1992).
Antibodies are generally known to be involved in the
recognition and elimination of foreign pathogens. Antibody
engineering technology represents the basis for savf clinical
use of antibodies. Recombinant antibodies allow large-scale
production and decrease the risk of transmission of infec-
tions associated with blood-derived products. Within the
last decade, many antiviral antibodies have been developed.
For example, the humanized recombinant antibody Synagis
(Schenerman et al., 1999) has been licensed for an infec-
tious disease indication. To our knowledge there is no pub-
lication about clinical trials concerning an immunotherapy
of HFRS. However, some neutralizing monoclonal antibod-
ies against members of the genus Hantavirus, derived from
mouse or human, have been described to passively protect
animals from challenges with HTN, SEO, and PUU viruses
(Antoniadis et al., 1989; Arikawa et al., 1992; Guttieri et al.,
2000; Liang et al., 1996, 1997; Salonen et al., 1998;
Schmaljohn et al., 1990; Zhang et al., 1989).
Therefore, the aim of our study was to generate fully
human recombinant antibodies capable of neutralizing Han-
taan virus employing phage display technology for selec-
tion. Five fully human recombinant IgG antibodies could be
produced in a baculovirus expression system and they were
shown to neutralize HTN and SEO virus in a plaque reduc-
tion neutralization test (PRNT). Three of these antibodies
could also completely neutralize DOB but not PUU virus.
Since HFRS patients remain viremic during the acute
phase of hantavirus infection, these neutralizing human re-
combinant antibodies might prove useful for the develop-
ment of an agent for prevention and treatment of HFRS in
patients.
Results and discussion
Construction of phage display libraries and panning on
native Hantaan virus particles
Two Fab antibody phage libraries, one derived from
cDNA isolated from peripheral blood lymphocytes (PBLs)
of a single reconvalescent HFRS patient (Y) and the other
derived from a mixture of four different patients (M) were
used for panning on native HTN (76-118) virus particles
propagated in Vero-E6 cells. The complexity of the two
libraries deduced from the number of transformants derived
after cloning of the antibody heavy chain (VH) genes was
determined to be 1.0  106 for the Y-library and 2.1  106
for the M-library. The most crucial step in the generation of
the recombinant antibodies described in this study was the
panning procedure. In contrast to other published work, we
used native HTN virus particles which were propagated in
Vero-E6 cells as a target for the selection of antibody
clones. Since the epitope of antibodies which are capable of
neutralizing hantaviruses is believed to be conformational,
panning on native virus particles provides a better chance to
select for neutralizing antibodies when compared with ap-
proaches using chemically purified recombinant protein as
antigen for panning.
The panning procedure was performed on the basis of the
protocols published by Parmley and Smith (1988) and Bar-
bas et al. (1991). After removal of nonspecific antibody
phage, the bound phages were eluted and reamplified in
Escherichia coli XL1-blue bacteria. This enrichment pro-
cess was repeated for a total of three cycles. Soluble Fab
fragments expressed from single clones selected after each
round of panning were tested for their binding properties on
HTN virus particles.
Following expression of soluble Fab fragments, the su-
pernatants containing Fab antibodies were used in immu-
nofluorescence and ELISA studies.
After the third round of panning, all of the Fab clones
obtained from Y and the M-library could bind to native
HTN particles in ELISA and to Vero-E6 cells infected with
Hantaan virus in an immunofluorescence assay. Nonin-
fected Vero-E6 cells probed with the Fab fragments showed
no fluorescence signal. However, none of the clones ana-
lyzed after the first round of panning were found positive
(data not shown). None of the positive clones tested reacted
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with the recombinant nucleocapsid (N) proteins of HTN and
PUU in a commercial ELISA test (data not shown), indi-
cating that the native shape of the HTN virus particles used
for panning could be maintained during purification from
Vero-E6 cells.
Sequence analysis of the Hantaan-specific Fab fragments
The variable regions of heavy (VH) and light (VL)
chain genes of individual antibody clones from the Y-
library (24 clones) and from the M-library (20 clones)
isolated after the third round of panning were sequenced
and their corresponding amino acid sequences were
aligned using the program CLUSTALW (Thompson et
al., 1994). Three sets of VL sequences were obtained
which are similar in their CDR sequences. Altogether, 10
different VL sequences could be isolated. In contrast,
only two different sequences were found for VH. Using
the DNAPLOT program for alignment to the V BASE
database, the germ line and gene families of the isolated
antibodies could be identified. The gene families were of
the VL1, VL2, and VKIII types and of VH3 type accord-
ing to Kabat et al. (1987). The five clones showing the
strongest binding to native Hantaan viruses were used for
further analysis. Their CDR sequences of the antibody
light chains are shown in Table 1.
We believe that the low number of antibodies derived in
this study underlines the importance of these antibodies for
the development of a therapeutic agent against hantaviruses.
During affinity maturation and clonal selection in the course
of an immune response, antibodies with high affinity and
beneficial specificity with regard to virus neutralization are
selected and highly overexpressed. Therefore antibodies
which have helped to cure the patient are more likely to be
selected during panning than others.
Baculovirus expression of fully human recombinant
antibodies
Four of the clones derived from the Y-library and one of
the mixed library were transformed into fully human IgG1
antibodies in the baculovirus expression cassette vector sys-
tem as described recently by Liang et al. (2001). The ex-
pression of antibody light chains was controlled by the P10
promoter and that of the antibody heavy chains was con-
trolled by the Polyhedrin promoter. Following transfection
of Sf9 cells with recombinant baculovirus, the expression of
antibody chains was monitored in an immunofluorescence
assay with Fab- and Fc-specific antibodies as described by
Liang et al. (2001). The fully human IgG1 antibodies were
correctly assembled to complete IgG molecules as shown by
Western blot analysis of protein A purified antibodies from
H5 cells under nonreducing conditions (Fig. 1). A commer-
cially available human reference IgG showed an identical
mobility in SDS–PAGE when compared with the recombi-
nant antibodies (Fig. 1). The presence of light and heavy
chains was determined by Western blot analysis under re-
ducing conditions (Fig. 1).
Table 1
CDR3 sequences of the VL-chains of five selected human recombinant
antibodies derived from panning on native Hantaan virus particles
Antibody VL-CDR1 VL-CDR2 VL-CDR3
M7 TGSSSNIGAGYDVH GNSNRPS QSYDSRLSGVV
Y1 TGTRSDVGGYNSVS DVSHRPS SSYTNSDTLI
Y5 TGTSSDVGGYNYVS DVSNRPS SSRRSGSTMG
Y7 TGTSSDVGDYNYVS DVSNRPS SSRRSGSTMV
Y22 TGTSSDVGGYNYVS DVSNRPS SSRRSGSTMV
Fig. 1. Immunoblot of fully human recombinant, protein A purified antibodies from insect cells. The recombinant antibodies were separated by SDS–PAGE
(12% PAA) under reducing (A) and nonreducing (B) conditions. Following transfer to nitrocellulose membranes, antibody chains were detected with a
HRP-conjugated goat anti-human (HL)-specific antibody. A human IgG1 sample purified from serum was used for reference under nonreducing conditions.
M7, Y1, Y5, Y7, Y22: different clones of human recombinant antibodies; H: antibody heavy chains; L: antibody light chains.
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Specificity of the human recombinant antibodies
Immunofluorescence analysis of the human recombinant
antibodies on Vero-E6 cells infected with different hanta-
virus species showed that four antibodies could bind to all
four of the most abundant hantavirus species causing HFRS
(DOB, HTN, PUU, SEO); a fifth antibody recognized HTN
and DOB virus only (Fig. 2). The overall intensity of the
fluorescence signal obtained with clones Y5 and Y22 was
significantly higher than with the other antibody clones. A
similar observation has been described in the literature for
certain G2-specific but not G1-specific monoclonal antibod-
ies to HTN virus, which reacted to the same titer with DOB
virus and homologous viral antigen (Avsic-Zupanc et al.,
1995).
Since none of the antibodies bound to HTN-N protein in
ELISA and since native HTN virus particles were used for
panning of the antibody phage libraries, the antibodies were
most likely directed against either G1 or G2 glycoproteins.
Therefore, the specificities of the protein A purified re-
combinant human antibodies were determined by immuno-
precipitation of recombinant HTN-M proteins produced in
insect cells (Shi et al., 1995). The mouse monoclonal anti-
bodies 11E10 directed against HTN-G2 and L13F3 directed
against hantavirus N protein were used for reference. All
antibodies analyzed precipitated HTN-G2 protein (Fig. 3).
Two additional proteins of about 80 kDa of unknown iden-
tity were coprecipitated. These impurities could be due to
incomplete cleavage products of the HTN-M precursor pro-
tein or to heterodimers consisting of one G2 protein and a
breakdown product of G1 protein (Liang et al., 1997). This
suggestion would be in line with the observation that some
monoclonal antibodies such as the HTN-G1 specific anti-
body 2D5 were found to precipitate both the HTN-G1 and
the HTN-G2 protein, although competition analysis re-
vealed it to be G1 specific (Arikawa et al., 1989). Even
though the G1 MAb did not recognize the heterodimeric
complex, it can be envisioned that the epitope of the G1
MAb within the G1 fragment is hidden because of a highly
complex structure formation of G1/G2 dimer. Furthermore,
insect cells represent an artificial expression system for the
HTN virus M-RNA with a different spectrum of proteases
when compared to cells being permissive hosts for hanta-
virus infection. Therefore, it could be possible that addi-
tional cleavage products are produced than during regular
cotranslational cleavage of the M precursor protein. We
consider G2 as the target for the antibodies because of the
correlation between G2 as the prominent band in the gel and
the fact that no peptides were recognized in peptide arrays
other than those of G2 (data not shown).
Fig. 2. Immunofluorescence of fully human recombinant antibodies on Vero-E6 cells infected with different hantaviruses causing HFRS. Vero-E6 cells
infected with Hantaan (HTN, 76–118), Seoul (SEO, R22), Puumala (PUU, 83-223L), or Dobrava (DOB, 907/5) virus were probed with protein A purified
human recombinant antibodies (10 ng/l). Bound antibodies were detected with a FITC-conjugated goat anti-human, Fab specific antibody. M7, Y1, Y5, Y7,
Y22: different clones of human recombinant antibodies. Slides taken from cells infected with a particular hantavirus species were identically exposed (HTN,
15 s; SEO, 16 s; PUU, 18 s; DOB, 30 s). The size bar corresponds to 1 m.
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Neutralization of hantaviruses
To analyze the ability of the human recombinant anti-
bodies purified from cell-culture supernatant of insect cells,
to block virus infection, we performed plaque reduction
neutralization and chemiluminescent focus reduction neu-
tralization tests as described by Schmaljohn et al. (1988)
and Heider et al. (2001) respectively. All five antibodies
could protect Vero-E6 cells from infection with HTN (76-
118) and SEO (HR-8039) virus. In addition, the most prom-
ising candidates for the development of an agent for the
protection and therapy of HFRS in patients (M7, Y5, Y22)
could also neutralize DOB virus but failed to significantly
reduce infectivity of PUU virus (data not shown). Depend-
ing on the antibody tested and the hantavirus species, neu-
tralization was achieved by preincubation of 100 PFU of the
virus with 0.55 to 3.3 g of recombinant IgG antibody
(Table 2). The amounts of antibody needed for neutraliza-
tion are comparable to published PRNT data for other an-
tibodies. Liang et al. (1996) could show 100% neutraliza-
tion of HTN (76-118) and SEO (SR-11) viruses by 0.7–5 g
of several HTN-G1 and HTN-G2 specific mouse monoclo-
nal antibodies. Furthermore, 1.5 g of the PUU-G2 specific
antibody 1C9 could neutralize PUU (K27) viruses by 100%
(Liang et al., 1997). Guttieri et al. (2000) report 80% neu-
tralization of PUU (K27) viruses with 0.3 g of two PUU-
G2-specific human recombinant antibodies purified from
insect cells.
Epitope mapping of the human intact antibodies to
Hantaan virus G2 protein
To investigate the binding sites of the human recombi-
nant IgG antibodies, we probed overlapping oligopeptides
(15mers offset by three amino acids) of the HTN (76–118)
virus glycoprotein G2 (Accession No. M14627), with the
recombinant human antibodies. We could identify two
epitope regions (aa 910–930 and aa 948–969) in arrays with
peptides offset by three amino acids which are detected by
all recombinant antibodies (data not shown). Employing
arrays with 15mer peptides offset by one amino acid, we
could detect two partial epitopes, 916-KVMATIDSF-924
and 954-LVTKDIDFD-963, which are recognized by all
recombinant antibodies analyzed (Fig. 4). The control anti-
body 100 IgG directed against the HTN-G1 protein (Liang
et al., 2003) as well as the detection antibody alone showed
no binding to these peptides (data not shown).
Exchanging of all amino acid positions within the bound
peptides against glycine or alanine followed by incubation
with the recombinant antibodies, we could identify the con-
sensus motif 916-KVXATIXSF-924 within one of the two
epitope regions. For the second partial epitope 954-LVTK-
Fig. 3. Immunoprecipitation of recombinant HTN-G2 protein from insect
cells. H5 cells expressing the HTN virus M-RNA were lysed and the entire
soluble protein was biotinylated. The labeled protein was incubated with
different protein A purified human recombinant antibodies and two mono-
clonal reference antibodies. Immunocomplexes were bound to protein A
agarose beads. After boiling, the samples were separated by SDS–PAGE
(10% PAA) and transferred to nitrocellulose membranes. Biotinylated
protein was detected with a streptavidin–HRP conjugate. 11E10: mono-
clonal antibody against HTN-G2 protein; L13F3: monoclonal antibody
against HTN-, PUU-, and SEO-N protein; M7, Y1, Y5, Y7, Y22: different
clones of human recombinant antibodies.
Table 2
Neutralization of hantaviruses by human recombinant antibodies
Specificity Antibody HTN (76–118) SEO (HR-8039) DOB (Slovenia)
[g] (%) [g] (%) [g] (%)
G2 M7 0.75 (100) 3 (100) 1.5 (97)
G2 Y1 1.63 (100) 3.3 (100) n.d.
G2 Y5 0.78 (100) 1.56 (100) 1.5 (97)
G2 Y7 1.56 (80) 1.56 (80) n.d.
G2 Y22 0.55 (100) 0.55 (100) 0.75 (100)
G1 100 IgG 0.6 (100) — —
Np 30 IgG — — —
Note. 100 PFU of HTN (76–118), SEO (HR–8039), DOB (Slovenia), viruses were preincubated with different amounts of protein A purified human
recombinant antibodies prior to infection of Vero-E6 cells in a plaque reduction neutralization test (PRNT). The amounts of antibody necessary to achieve
a certain percentage of virus neutralization are shown. M7, Y1, Y5, Y7, Y22: different clones of human recombinant antibodies; 100 IgG: human recombinant
antibody against HTN-G1 protein; 30 IgG: human recombinant antibody against HTN-N protein.
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DIDFD-963 amino acid exchanges in any position led to a
loss in reactivity (data not shown).
Since all of the human recombinant antibodies could
neutralize HTN, DOB, and SEO virus in a PRNT assay, we
believe that at least one of the two partial epitopes identified
plays a crucial role in virus infection. This suggestion is
supported by the findings of Heiskanen et al. (1999), who
could detect binding sites for two neutralizing monoclonal
mouse antibodies (1C9 and 4G2) and for an early conva-
lescent-phase patient serum (S1b) as well as an acute-phase
patient serum (S3b) within the PUU-G2 protein located in a
homologous region recognized by our recombinant antibod-
ies within the HTN-G2 sequence (Fig. 5). The alignment of
the amino acid sequence of the four viruses (HTN, DOB,
SEO, PUU) revealed a sequence identity of 75% in the
sequence stretch of interest between the species HTN, DOB,
and SEO. The sequence identity found between these viral
amino acid sequences and that of PUU virus is much lower.
Furthermore, the antibodies M7, Y5, and Y22 presented in
this study can neutralize HTN, DOB, and SEO virus to a
comparable extent, whereas they fail to neutralize PUU
virus (see Table 2). This finding is in line with data deduced
from phylogenetic tree analyses clearly demonstrating that
HTN, DOB, and SEO viruses are more closely related to
each other than to PUU virus (Schmaljohn and Hjelle,
1997). Furthermore, the glycoproteins in the virus envelope
seem to form a very complex spike-shaped structure (Griot
et al., 1993), suggesting that a prerequisite for neutralizing
antibodies against hantavirus is the recognition of a confor-
mational epitope. Since peptide arrays comprised short lin-
ear overlapping peptides, the elucidation of conformational
epitopes is hampered. However, it has been achieved in rare
cases (Frank and Schneider-Mergener, 2002). A prerequi-
site for such analyses is that the single affinities of the
antibody to each individual partial epitope is high enough to
be detectable. Nevertheless, the pepscan approach repre-
sents a powerful tool to specifically detect at least a pro-
portion of binding sites within a protein.
Hantavirus infections are most probably mediated by
3-integrin. This suggests that common elements exist on
G1 or on the more highly conserved G2 surface glycopro-
tein, which appear to be responsible for the attachment of
Fig. 4. Epitope mapping of fully human recombinant antibodies on solid-phase oligopeptides of the HTN-G2 protein. Solid-phase oligopeptides (15mers
offset by one amino acid) of the HTN-G2 protein (Accession No. M14627) were synthesized on amino-PEG membranes as described (Koch and Mahler,
2002). The peptides were probed with 1 g/ml of different clones of protein A purified human recombinant antibodies. Bound antibodies were detected with
a HRP-conjugated goat anti-human (HL)-specific antibody. Films were exposed for 1 min. The numbers of the peptide spots are given on the right. The
epitope regions (i, ii) identified for the neutralizing human recombinant antibodies are exemplarily shown for the antibody Y22.
Fig. 5. Alignment of the epitope regions for neutralization of hantaviruses. Alignment of the epitopes identified for the neutralizing human recombinant
antibodies on the HTN-G2 protein selected in this study (Fig 4; i, ii), and the corresponding amino acid sequence stretch within DOB (907/5), SEO (8039),
and PUU (Sotkamo) viruses (A). The amino acid residues labeled with a plus are critical for antibody binding to the first partial epitope identified in this study.
Sequential exchange of these residues to glycine or alanine led to loss in reactivity (data not shown). The binding sites for the neutralizing PUU-G2-specific
monoclonal antibodies 4G2 and 1C9, an early convalescent-phase serum (S1b) and an acute-phase serum (S3b) on the PUU-G2 protein identified by
Heiskanen et al. (1999), are underlined (B).
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virus particles to integrins (Mackow and Gavrilovskaya,
2001). However, the virion attachment protein has not been
defined. The 3-integrins are critical adhesive receptors on
platelets and endothelial cells and regulate vascular perme-
ability and platelet activation and adhesion (Mackow and
Gavrilovskaya, 2001). Therefore, these receptors as well as
the virion counterparts might be of particular importance in
hantavirus pathogenesis.
Since the neutralizing antibodies directed against hanta-
viruses generated in this study recognize all important
HFRS-related hantavirus species and since they effectively
neutralize HTN, SEO, and DOB virus, we believe that they
are highly promising candidates for the development of an
immunotherapy of HFRS.
Materials and methods
Cells and viruses
H5 cells (Trichoplysia ni; Pharmingen) were grown in
TC100 medium, 10% (v/v) fetal calf serum, L-glutamine,
and penicillin-streptomycin (all Life Technologies) at 27°C.
Vero-E6 cells (ATCC C1008, CRL1586, passage 7–10)
were grown in DMEM, 10% (v/v) fetal calf serum, L-
glutamine, and penicillin-streptomycin (all Life Technolo-
gies) at 37°C, 95% humidity, and 5% CO2. Biosafety level
3 (BSL-3) facilities were used throughout these experiments
for the growth of Hantaan (HTN, strain 76–118), Seoul
(SEO, strain HR-8039), and Dobrava (DOB, Strain Slov-
enia) virus.
Propagation and purification of hantaviruses
Vero-E6 cells were infected with Hantaan virus (HTN,
strain 76–118) or Seoul virus (SEO, strain HR-8039) at an
m.o.i. of 0.15 and cultivated for 8 days. The medium su-
pernatant was harvested and replaced by fresh supple-
mented DMEM medium followed by incubation for another
3 days previous to a second harvest of culture medium
containing virus particles. Culture supernatants were clari-
fied by centrifugation at 10,000g for 30 min at 4°C and
sterile filtered through a 0.22-m filter. Virus particles were
pelleted through a 30% sucrose cushion (in TNE buffer: 10
mM Tris–HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA) in an
ultracentrifuge at 72,000g for 2 h at 4°C using a SW-28
rotor. The virus pellets were resuspended in 500 l of TNE
buffer per 210 ml of culture supernatant. The identity of the
virus was confirmed in ELISA and by SDS–PAGE analysis.
Construction of phage display libraries
Phage display libraries were constructed in the bacterial
expression vector pComb3 kindly provided by Dr. Dennis
Burton (The Scripps Research Institute, La Jolla, CA,
USA). Blood was drawn from four reconvalescent HFRS
patients 2–3.5 months after onset of the disease in the Anhui
province in China where no species other than HTN had
been observed. All patients’ sera were tested in an ELISA
assay and appeared to contain only antibodies against Han-
taan virus (data not shown). Extraction of mRNA and
cDNA synthesis were performed as described (Koch and
Du¨bel, 2001). The heavy and light chain genes (Fab) were
amplified using the primer set published by Kang et al.
(1991). The PCR products were cloned into pComb3 to
create the Fab fragment phage libraries (Barbas and Lerner,
1991; Barbas et al., 1991).
Panning of the combinatorial libraries on native Hantaan
virus particles
The panning procedure employed for this study is a
modification of those described by Parmley and Smith
(1988) and Barbas et al. (1991). For each library, six wells
of a microtiter plate (Maxisorp, Life Technologies) were
coated with 3  106 PFU of native, Vero-E6 cell-derived
HTN particles in 100 l of 0.1 M NaHCO3, pH 8.6 over-
night at 4°C. The wells were washed twice with deionized
water and unspecific binding sites were blocked with 400
l/well of 3% skim milk powder (OXOID) in PBS (137
mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1 mM KH2PO4, pH
7.3) for 1 h at 37°C. The blocking solution was removed and
100 l of phage library (typically 1012 PFU) was added per
well and incubated for 2 h at 37°C. The plates were washed
once with deionized water followed by washing 10 times
with 400 l per well of PBS supplemented with 0.05%
Tween 20 over a period of 1 h. The plates were again
washed once with deionized water. Bound antibody phages
were eluted with 100 l per well of 0.1 M HCl (adjusted to
pH 2.2 with solid glycine) supplemented with 2% (w/v) of
bovine serum albumin (BSA, fraction V, SERVA) for 10
min at RT. The eluates from corresponding wells were
immediately collected and neutralized with a total volume
of 600 l of 1 M Tris–HCl, pH 7.5. The eluted phages were
reamplified by infecting 2 ml of freshly prepared XL1-blue
bacteria (OD600 1, Stratagene) for 15 min at 37°C without
shaking. Ten milliliters of prewarmed dYT medium supple-
mented with ampicillin (20 g/ml) and tetracycline (10
g/ml) were added and aliquots for titration of the eluted
phage particles were taken and plated out as described by
Barbas et al. (1991). The cultures were incubated for 1 h at
37°C in a shaker and transferred into 100 ml of prewarmed
dYT medium containing ampicillin (50 g/ml) and tetracy-
cline (10 g/ml). After shaking at 37°C for 1 h 1012 PFU of
M13K07 helperphage (Amersham Pharmacia Biotech) was
added in a volume smaller than 500 l and the cultures were
shaken for 2 h at 37°C. After adding kanamycine (70 g/
ml) the cultures were shaken overnight at 37°C. The culture
supernatants were clarified by centrifugation for 20 min at
6000 g at 4°C and transferred to fresh tubes. Antibody
phages were precipitated by adding solid PEG8000 [16%
(w/v), SERVA] and solid NaCl (3.3 M) to the supernatants
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followed by incubation for 30 min on ice. Precipitated
phages were recovered by centrifugation at 13,000 g for 20
min at 4°C and resuspended in 2 ml of phage dilution buffer
(10 mM Tris–HCl, pH 7.5, 20 mM EDTA, 2 mM NaCl) and
100 l/well of the recovered phage was used for further
rounds of panning. After each round of panning single
bacteria colonies were taken from the titration plates (see
above) and used for the expression of soluble Fab fragments
and sequence analysis.
Expression of soluble Fab fragments
Single bacteria colonies recovered during the panning
procedure were transferred into 5 ml of dYT medium con-
taining ampicillin (50 g/ml) and tetracycline (10 g/ml)
and grown to an OD600 of 0.2. Expression of soluble Fab
fragments was induced with 1 mM IPTG for 12 h on a
shaker at 37°C. Bacteria were collected by centrifugation at
3500 g for 20 min at 4°C and resuspended in 200 l PBS.
The cells were lysed by three cycles of freezing in liquid
nitrogen and subsequent thawing in a 37°C water bath. Cells
were frozen again and cell debris was pelleted at 16,000 g
in a microcentrifuge at room temperature for 20 min. The
supernatant containing the soluble Fab:pIII fragments was
used in immunofluorescence assays and ELISA.
Binding of soluble Fab fragments to native Hantaan virus
particles in ELISA
Microtiter plates (Maxisorp, Life Technologies) were
coated with 106 PFU of native Vero-E6 cell-derived HTN
particles in 100 l of 0.1 M NaHCO3, pH 8.6 overnight at
4°C. Unspecific binding sites were blocked with 400 l/
well of 3% skim milk powder (OXOID) in PBS containing
0.05% Tween 20 (PBS-T) for 1 h at 37°C. The blocking
solution was removed and 100 l of the soluble Fab:pIII
fragments derived from bacteria lysate were added to each
well followed by incubation for 1 h at 37°C. The wells were
washed three times with PBS-T and bound Fab fragments
were detected with an anti-human IgG (Fab-specific) HRP-
conjugated antibody (Sigma) for 1 h at RT.
Immunofluorescence on hantavirus-infected Vero-E6 cell
slides
Vero-E6 cells infected with Hantaan (76–118), Seoul
(R22), Puumala (83–223L) (all Progen), or Dobrava (907/5)
virus (kindly provided by T. Avsic-Zupanc, Medical Fac-
ulty of Ljubljana, Ljubljana, Slovenia) were probed with
protein A purified human recombinant antibodies (10 ng/l)
or 50 l of soluble Fab:pIII fragments derived from bacteria
lysate for 30 min at 37°C. The wells were washed three
times with PBS-T and the bound antibodies (fragments)
were detected with a FITC-conjugated goat anti-human,
Fab-specific antibody (Sigma) for 30 min at 37°C.
Baculovirus expression and purification of human
recombinant antibodies
Depending on the subclass of the VL chain, the VL and
VH Fab genes were cloned into the vectors pAc-K-Fc or
pAc-L-Fc, respectively, as described previously by Liang et
al. (2001). The procedure for the preparation of recombinant
baculovirus based on homologous recombination using the
Baculo-Gold transfection kit (Pharmingen) was published
elsewhere (Liang et al., 2001). Sf9 and H5 cells (Pharmin-
gen) were infected with recombinant virus containing the
DNA encoding human IgGs at an m.o.i. of 10 and were
grown in Express Five SFM medium supplemented with
glutamine and penicillin/streptomycin. The cells were incu-
bated in T182 flasks for 4 to 5 days at 27°C until 50–60%
of floating cells were observed. The IgG containing cell
supernatants were clarified by centrifugation at 5000 g for
20 min at 4°C and filtered through a 0.22-m filter. The
IgGs were affinity purified using HiTrap rProtein A col-
umns (Amersham Pharmacia Biotech). Elution from the
column was done with 0.1 M sodium citrate, pH 2.7 fol-
lowed by immediate neutralization with 1 M Tris–HCl, pH
8.5. The samples were desalted using PD-10 desalting col-
umns (Amersham Pharmacia Biotech) and recovered in
PBS. IgG concentrations were determined by ELISA in
comparison to a human IgG of known titer (Sigma).
SDS–PAGE and immunoblotting of recombinant IgGs
The purified IgGs were analyzed by SDS–PAGE under
nonreducing and reducing conditions. Immunostaining was
done with a monoclonal goat anti-human antibody (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA) rec-
ognizing total IgG and IgM, and visualized with TMB
substrate (Progen).
Immunoprecipitation of Hantaan virus M protein
The immunoprecipitation of Hantaan virus glycoproteins
from H5 cells expressing HTN virus M-RNA was per-
formed with the Cellular Labelling and Immunoprecipita-
tion Kit (Roche Diagnostics), and biotinylated protein was
detected with a streptavidin–HRP conjugate (Roche Diag-
nostics), according to the manufacturer.
Solid-phase oligopeptide assays
Oligopeptides, covering the entire sequence of the
HTN-G2 protein (76–118, Accession No. M14627), were
synthesized on activated cellulose membranes employing
the SPOT-robot ASP222 (Abimed) as described (Koch and
Mahler, 2002). 15mer oligopeptides of the HTN-G2 wild-
type sequence as well as mutated peptides with sequential
exchange of all amino acids against glycine or alanine were
generated. Following blocking of unspecific binding sites,
the peptides were probed with 1 g/ml of human recombi-
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nant antibodies purified from H5 cell-culture supernatant for
2 h at room temperature. The membranes were washed three
times for 5 min with TBS/0.2% Tween 20 (TBS-T) and
three times with TBS. Bound antibody was detected with a
goat anti-human HRP-conjugated antibody (Jackson Immu-
noResearch Laboratories). Peroxidase activity was visual-
ized with ECL-detection reagent (Amersham Pharmacia
Biotech).
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